CCP grants exemptions to logistics and transport sector
The Competition Commission of Pakistan (CCP) has granted two conditional exemptions to undertakings in the transport and logistics sector, permitting limited restrictive provisions under joint venture agreements aimed at strengthening Pakistan's logistics capabilities.
According to a press statement released on Monday, the exemptions were approved following a comprehensive review by CCP's Exemptions Department, which assessed the legal framework, potential market impact, and the long-term investment plans associated with the proposed collaborations.
'These arrangements were found to satisfy the requirements set out in Section 9 of the Competition Act, 2010. The joint ventures are expected to foster technical progress, enhance operational efficiency, and improve service standards in the logistics and freight sectors,' read the statement.
CCP grants six exemptions to pharma sector
CCP observed that the joint ventures will leverage international best practices alongside local expertise, contributing to infrastructure development, innovation, and greater consumer value.
Specific provisions within the shareholders' agreements—such as non-compete and exclusivity clauses—were conditionally approved to ensure investment protection and coordination, while safeguarding against risks of market foreclosure.
These approvals reaffirm CCP's commitment to facilitating strategic business collaboration that supports economic growth, while ensuring that competition remains open, fair, and free from abuse of dominance, said CCP.
'All exemptions are subject to strict compliance with conditions designed to preserve competitive dynamics in the market,' read the statement.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
10 hours ago
- Business Recorder
CCP grants exemptions to logistics and transport sector
The Competition Commission of Pakistan (CCP) has granted two conditional exemptions to undertakings in the transport and logistics sector, permitting limited restrictive provisions under joint venture agreements aimed at strengthening Pakistan's logistics capabilities. According to a press statement released on Monday, the exemptions were approved following a comprehensive review by CCP's Exemptions Department, which assessed the legal framework, potential market impact, and the long-term investment plans associated with the proposed collaborations. 'These arrangements were found to satisfy the requirements set out in Section 9 of the Competition Act, 2010. The joint ventures are expected to foster technical progress, enhance operational efficiency, and improve service standards in the logistics and freight sectors,' read the statement. CCP grants six exemptions to pharma sector CCP observed that the joint ventures will leverage international best practices alongside local expertise, contributing to infrastructure development, innovation, and greater consumer value. Specific provisions within the shareholders' agreements—such as non-compete and exclusivity clauses—were conditionally approved to ensure investment protection and coordination, while safeguarding against risks of market foreclosure. These approvals reaffirm CCP's commitment to facilitating strategic business collaboration that supports economic growth, while ensuring that competition remains open, fair, and free from abuse of dominance, said CCP. 'All exemptions are subject to strict compliance with conditions designed to preserve competitive dynamics in the market,' read the statement.
Business Recorder
4 days ago
- Business Recorder
Pharmaceutical sector: CCP grants six exemptions to undertakings for FY2024–25
ISLAMABAD: In line with its mandate to promote fair competition and protect consumer welfare, the Competition Commission of Pakistan (CCP) has granted six exemptions to undertakings in the pharmaceutical sector for the fiscal year 2024–25, under Section 5 of the Competition Act, 2010. These exemptions relate to specific restrictive clauses in commercial agreements — such as territorial exclusivity and non-compete provisions that would ordinarily be considered anti-competitive under Section 4 (Prohibited Agreements) of the Act. However, after conducting rigorous due diligence, including a detailed assessment of market structures, sector-specific regulations, and the commercial terms of the agreements, CCP determined that the arrangements in question contribute to production efficiency, technological advancement, and enhanced consumer access to critical pharmaceutical products. The Commission noted that these exemptions are expected to improve service delivery, increase the availability of medicines in underserved regions, and lead to better public health outcomes. Consumers stand to benefit from access to advanced pharmaceutical technologies, more reliable product information, and higher standards of service. Each exemption was granted for a specific duration and is subject to conditions that ensure the pro-competitive benefits clearly outweigh any potential adverse effects on competition. Importantly, the undertakings are required to avoid any form of price-fixing or collusive conduct, and pricing arrangements remain outside the scope of these exemptions. The pharmaceutical sector remains a priority area for CCP's exemption regime, with the Commission maintaining close coordination with relevant health regulators to ensure that such decisions serve the broader public interest. Copyright Business Recorder, 2025
Business Recorder
4 days ago
- Business Recorder
CCP grants six exemptions to pharma sector
The Competition Commission of Pakistan (CCP) has granted six exemptions to undertakings in the pharmaceutical sector for the fiscal year 2024–25, under Section 5 of the Competition Act, 2010, read a press statement on Thursday. These exemptions relate to specific restrictive clauses in commercial agreements—such as territorial exclusivity and non-compete provisions—that would ordinarily be considered anti-competitive under Section 4 (Prohibited Agreements) of the Act, CCP said. However, after conducting rigorous due diligence, including a detailed assessment of market structures, sector-specific regulations, and the commercial terms of the agreements, CCP determined that the arrangements in question contribute to production efficiency, technological advancement, and enhanced consumer access to critical pharmaceutical products. The commission noted that these exemptions are expected to improve service delivery, increase the availability of medicines in underserved regions, and lead to better public health outcomes. 'Consumers stand to benefit from access to advanced pharmaceutical technologies, more reliable product information, and higher standards of service,' it said. The commission informed that each exemption was granted for a specific duration and is subject to conditions that ensure the pro-competitive benefits clearly outweigh any potential adverse effects on competition. 'Importantly, the undertakings are required to avoid any form of price-fixing or collusive conduct, and pricing arrangements remain outside the scope of these exemptions,' the commission stated. On Wednesday, the federal government, in an effort to boost pharmaceutical exports, announced the establishment of an empowered Pharma Export Promotion Council, PharmEx Pakistan, under the Trade Development Authority of Pakistan.
